Psychosocial and pharmacological treatment for pediatric anxiety disorders

Paige H. Fisher, Jonathan L. Tobkes, Lauren Kotchern, Carrie Masia-Warner

Research output: Contribution to journalReview articlepeer-review

12 Scopus citations


Anxiety disorders in children and adolescents are highly prevalent and associated with long-term impairment. This article reviews the main diagnostic features of the most common pediatric anxiety disorders, including specific phobia, separation anxiety disorder, generalized anxiety disorder and social anxiety disorder, and highlights the state-of-the-art treatments for these diagnoses. The most recent evidence for empirically supported treatments is described, namely cognitive-behavioral therapy and selective serotonin-reuptake inhibitors. The review concludes by providing practitioners with recommendations for treating pediatric anxiety and highlighting areas for further investigation.

Original languageEnglish
Pages (from-to)1707-1719
Number of pages13
JournalExpert Review of Neurotherapeutics
Issue number11
StatePublished - Nov 2006


  • Anxiety disorders
  • Children
  • Cognitive-behavioral therapy
  • Fluoxetine
  • Fluvoxamine
  • Paroxetine
  • Sertraline


Dive into the research topics of 'Psychosocial and pharmacological treatment for pediatric anxiety disorders'. Together they form a unique fingerprint.

Cite this